The French government has announced plans to double the annual cap on medical franchises, raising the limit from 100 to 200 euros. This change affects the out-of-pocket costs patients pay for medical consultations, laboratory tests, and prescription medications. By increasing this ceiling, the state aims to adjust the financial contribution of citizens toward the national healthcare system, which is currently facing significant budgetary pressures.
Medical franchises are small, fixed fees that patients pay for each box of medicine or medical procedure, which are not fully reimbursed by the national health insurance. While these fees are capped annually to protect patients with chronic illnesses or high medical needs, the doubling of this limit means that more individuals will reach a higher total expenditure before the state covers the remainder of their costs for the year.
This policy shift is part of a broader effort to manage the rising costs of the French social security system. Officials have pointed to the need for fiscal responsibility as the demand for healthcare services continues to grow alongside an aging population. The government maintains that this adjustment is a necessary step to ensure the long-term sustainability of the public health insurance model.
Patients who frequently visit doctors or require regular medication will be the most impacted by this change. While the increase is designed to be manageable for the average household, it represents a direct rise in the cost of living for those with recurring health issues. The government has noted that exemptions will remain in place for certain vulnerable groups, such as children and those receiving specific state-funded medical support.
As the policy moves toward implementation, the public and medical unions are closely monitoring the potential impact on patient access to care. The government is expected to finalize the details of the rollout in the coming months, with health authorities tasked with communicating the changes to the public to ensure clarity regarding the new annual limits.